by Thomas Derrick Hull, PhD | Jul 26, 2022 | Uncategorized
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial Presented on Tuesday 26th July 2022 | 12.30pm EST | 5.30pm UK Thomas D Hull,...
by David Mathai, MD and Scott Lee, MD | Jul 12, 2022 | Uncategorized
Mapping consent practices for outpatient psychiatric use of ketamine Presented on Tuesday 12th July 2022 | 12.30pm EST | 5.30pm UK David S Mathai, Scott M Lee, Victoria Mora, Kelley C O’Donnell, Albert Garcia-Romeu, Eric A Storch. J Affect Disord. 2022 Sep...
